Detalles de la búsqueda
1.
Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response.
BMC Cancer
; 22(1): 332, 2022 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35346116
2.
Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia.
J Oncol Pharm Pract
; 27(7): 1644-1656, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33040675
3.
Correction to: Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial.
Support Care Cancer
; 28(7): 3249, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31811487
4.
Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial.
Support Care Cancer
; 28(7): 3237-3247, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31734798
5.
Potential CD34 signaling through phosphorylated-BAD in chemotherapy-resistant acute myeloid leukemia.
J Recept Signal Transduct Res
; 39(3): 276-282, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31509041
6.
Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.
Int J Med Sci
; 16(4): 556-566, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31171907
7.
Health-related quality of life and psychological distress among cancer survivors in a middle-income country.
Psychooncology
; 27(9): 2172-2179, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29856903
8.
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
Lancet Oncol
; 17(3): 389-400, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26873565
9.
Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma.
Tumour Biol
; 36(3): 1819-34, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25384508
10.
A randomized double blind control trial comparing filgrastim and pegfilgrastim in cyclophosphamide peripheral blood hematopoietic stem cell mobilization.
Transfus Apher Sci
; 53(2): 196-204, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25910537
11.
Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population.
J Hum Genet
; 59(5): 280-7, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24646728
12.
Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panel.
BMC Med Genomics
; 15(1): 10, 2022 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35033063
13.
Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia.
J Immunol Res
; 2022: 7972039, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35652109
14.
Occult Disseminated Metastatic Breast Carcinoma Presenting as Acquired Thrombotic Thrombocytopenic Purpura.
Case Rep Oncol
; 14(3): 1814-1820, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35111014
15.
Construction of a microRNA-mRNA Regulatory Network in De Novo Cytogenetically Normal Acute Myeloid Leukemia Patients.
Genet Test Mol Biomarkers
; 25(3): 199-210, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33734890
16.
Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent Action.
J Oncol Pract
; 15(6): e537-e546, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31112479
17.
Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Cancer Genet Cytogenet
; 180(1): 60-4, 2008 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18068536
18.
Clinical characteristics and outcomes of thrombotic microangiopathy in Malaysia.
Blood Res
; 53(2): 130-137, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29963519
19.
The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia.
Exp Hematol Oncol
; 7: 31, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30564475
20.
Fludarabine, High Dose Cytarabine and Granulocyte Colony-Stimulating Factor (FLAG) as Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia: A Retrospective Cohort Study.
Indian J Hematol Blood Transfus
; 33(4): 483-491, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29075058